Khawaja Ammar is a Cardiology physician affiliated with Aurora Health Care. OpenAlex indexes 150 publications with 1,672 citations (h-index 15); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2801 W Kinnickinnic River Pkwy
Suite 175
Milwaukee, WI 532153669
Telephone
414-649-3626Provider last certified this registry record 19 Nov 2021.
Clinical trials
- Peripheral Venous Pressure (PVP) Trial
Sponsor: Wake Forest University Health Sciences
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Philips North America LLCProgram year20255 payments
- Medtronic, Inc.Program year20256 payments
- Penumbra, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
74.6%Beta blocker18.8%Metoprolol Succinate60%Carvedilol21%Nadolol6%Metoprolol Tartrate5%Atenolol4%Sotalol4%Propranolol Hcl Er2%Part D<11 patientsStatin12%Atorvastatin Calcium63%Rosuvastatin Calcium19%Pravastatin Sodium12%Simvastatin6%Part D≥132 patients+ 20 more classes in this area
Blood & clotting
16.4%P2Y12 inhibitor10.1%Clopidogrel74%Prasugrel Hcl13%Brilinta13%Part D≥122 patientsFactor Xa inhibitor5.4%Eliquis85%Xarelto16%Part D≥74 patients+ 2 more classes in this area
Metabolism & gastrointestinal
5.9%Potassium supplement3.2%Potassium Chloride83%Klor-Con M2017%Part D<11 patientsProton pump inhibitor1.4%Pantoprazole Sodium100%Part D≥25 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Nalini Guda, MD
Aurora Health Care
Steven Port, MD
Aurora Health Care
Suhail Allaqaband, MD
Aurora Health Care
Atul Bhatia, MD
Aurora Health Care
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”